CDT Equity Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
4851 TAMIAMI TRAIL NORTH, NAPLES, FL, 34103
Mailing Address
4851 TAMIAMI TRAIL NORTH, NAPLES, FL, 34103
Phone
(646) 491 9132
Fiscal Year End
1231
EIN
873272543
Financial Overview
FY2024
$7.22M
Total Assets
$4.23M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13D Beneficial ownership report (>5%) | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 6, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 18, 2026 | View on SEC |
Material Events
8-K
Financial Distress
March 25, 2026
High Impact
- 1-for-25 reverse stock split to maintain Nasdaq listing compliance
- Company aims to avoid demotion to 'Pink Sheets' trading
8-K
Strategy Change
March 18, 2026
High Impact
- Approval to issue new shares (pre-funded warrants, equity line of credit) to fund operations, accelerate R&D, and strengthen the balance sheet, providing significant financial flexibility.
- Ability to maintain Nasdaq listing through a reverse stock split, boosting per-share price.
8-K
Acquisition
February 24, 2026
High Impact
- Strategic acquisition of a 20% stake in Sarborg Limited, outlining CDT Equity Inc.'s strategic moves.
- Extensions of consulting agreements with NJS Foresight Bio-Advisory, LLC and Thesprogen, PC, indicating ongoing strategic partnerships.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.